Public company and medtech finance veteran to guide SEC reporting and financial strategy as GIPL progresses VetBreath Analytics
Global Innovative Platforms, Inc. (OTCMKTS:GIPL)
We believe his experience will strengthen our financial infrastructure and support our commitment to transparent reporting to shareholders.”— Andrew Brown, CEO, Global Innovative Platforms
Global Innovative Platforms, Inc. (OTCID: GIPL) ("GIPL" or the "Company"), the parent entity of VetBreath Analytics (VBA), disclosed today that its Board of Directors has selected David R. Wells for the role of Fractional Chief Financial Officer, effective October 1, 2026. Mr. Wells has additionally been named the Company’s principal financial officer and principal accounting officer.
Also worth a look: Nova Management Promotes Starr Rodenhurst to National Consultant, Driving Telecom Growth and The Business Research Company issues NAS gateways market report with forecasts and trends.
Mr. Wells brings over three decades of expertise in finance, operations, and administration, largely within medical device and technology enterprises. In this capacity, he will manage the Company’s accounting and financial reporting duties and bolster its SEC disclosures, financial planning, cash flow management, and financial modeling as the Company pushes forward with the VetBreath Dx platform.
"David has held senior finance positions at publicly traded firms and knows what is required to establish rigorous financial reporting at an early-stage company," remarked Andrew Brown, Chief Executive Officer of GIPL. "As we keep progressing VetBreath Analytics, we believe his experience will strengthen our financial infrastructure and support our commitment to transparent reporting to shareholders."
Andrew Brown will continue in his roles as Chief Executive Officer and as a Board of Directors member.
"I am pleased to join GIPL at this stage of its development," stated Mr. Wells. "VetBreath Analytics is pursuing a non-invasive approach to veterinary diagnostics, and I look forward to working with Andrew and the team to support the Company’s financial planning and public reporting."
About David R. Wells
Since July 2021, Mr. Wells has owned Atlas Bookkeeping, LLC, through which he delivers CFO advisory services to both public and private organizations. From August 2023 to May 2025, he acted as Chief Financial Officer for Envoy Medical, Inc. (Nasdaq: COCH). Between June 2021 and September 2022, he was Chief Financial Officer of GHS Investments, LLC, a private equity fund. Since December 2022, he has served on the Board of Directors for HeartSciences, Inc. (Nasdaq: HSCS). Mr. Wells earned a bachelor’s degree in finance and entrepreneurship from Seattle Pacific University and a Master of Business Administration from Pepperdine Graziadio Business School.
Mr. Wells provides his services to the Company through Atlas Bookkeeping, LLC under a Services Agreement dated October 1, 2026. Further information regarding the appointment and the Services Agreement can be found in the Company’s Current Report on Form 8-K submitted to the U.S. Securities and Exchange Commission.
About Global Innovative Platforms, Inc. and VetBreath Analytics
Global Innovative Platforms, Inc. (OTCID: GIPL) is a publicly traded firm whose animal health diagnostics arm, VetBreath Analytics, is creating a non-invasive, breath-based diagnostic platform. This platform merges breath capture, gas chromatography, and AI with chemometric modeling to evaluate volatile organic compounds, with an initial emphasis on canine heartworm identification. The technology remains in the development and validation phase, and the Company intends to assess its possible use for additional diseases and species over time.
